Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03502746
Title Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Arkadiusz Z. Dudek, MD
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
University of Maryland Baltimore Maryland 21201 United States Details
Karmanos Cancer Center (Wayne State University) Detroit Michigan 48201 United States Details
HealthPartners Institute Regions Cancer Care Center Minneapolis Minnesota 55440 United States Details
*Shaded cells indicate that there was no data available from for the field